Is PennTex Midstream Partners a good dividend stock?

PennTex Midstream Partners (NASDAQ:PTXP) pays an annual dividend of $1.18 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 85.51%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for PTXP .

What other stocks do shareholders of PennTex Midstream Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PennTex Midstream Partners investors own include Allena Pharmaceuticals (ALNA) , Arbutus Biopharma (ABUS) , Ampliphi Biosciences (APHB) , Aurora Cannabis (ACBFF) , AcelRx Pharmaceuticals (ACRX) , Aldeyra Therapeutics (ALDX) , Apellis Pharmaceuticals (APLS) , Aquinox Pharmaceuticals (AQXP) .

When did PennTex Midstream Partners IPO?

PennTex Midstream Partners (PTXP) raised $226 million in an initial public offering (IPO) on Thursday, June 4th 2015. The company issued 11,300,000 shares at $19.00-$21.00 per share. Citigroup, Barclays, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Deutsche Bank Securities, J.P. Morgan, SunTrust Robinson Humphrey, Tudor, Pickering, Holt & Co., Raymond James, Baird, Stifel and Wunderlich were co-managers.

NASDAQ:PTXP

PennTex Midstream Partners (PTXP) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free PTXP Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $20.00
▼
$20.00
50-Day Range: N/A
52-Week Range: $14.56
▼
$20.17

Volume: N/A
Average Volume: 163,825 shs
Market Capitalization: N/A

P/E Ratio: 14.49
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get PennTex Midstream Partners alerts:

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About PennTex Midstream Partners Stock (NASDAQ:PTXP)

PennTex Midstream Partners, LP, focuses on owning, operating, acquiring and developing midstream energy infrastructure assets in North America. The Company owns and operates midstream gathering, processing and transportation assets in northern Louisiana. The Company provides natural gas gathering and processing and residue gas and natural gas liquid (NGL) transportation services to producers focused on the Cotton Valley formation in northern Louisiana. The Company's assets primarily consisted of natural gas gathering pipeline, two 200 million cubic feet per day (MMcf/d) design-capacity cryogenic natural gas processing plants, and residue gas and NGL transportation pipelines, as of December 31, 2016. In addition to providing midstream services to its primary customer with its existing assets, the Company pursues other opportunities for organic development and growth as producers in its region continue to develop their acreage.

Ad InvestorPlace

Now Open: Crypto emergency update

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

PTXP Stock News Headlines

November 20, 2023 | morningstar.com

Hess Midstream LP Class A HESM

June 8, 2022 | investing.com

Penntex Midstream Partners LP (PTXP)

See More Headlines

Receive PTXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PennTex Midstream Partners and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:PTXP
CUSIP: N/A
CIK: 1617798
Web: penntex.com
Phone: +1-713-9897560
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 14.49
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Matthew S. Ramsey J.D.
Chairman of the Board, President, Chief Operating Officer
Kelcy L. Warren
Chief Executive Officer
Thomas E. Long
Chief Financial Officer, (Principal Financial Officer), Director
A. Troy Sturrock
Senior Vice President, Controller and Principal Accounting Officer
Stephen M. Moore
Vice President, General Counsel, Secretary
Thomas P. Mason
Director
Marshall S. McCrea III
Director
Robert W. Jordan
Independent Director
David C. Lawler
Independent Director
Richard S. Walker
Independent Director

PTXP Stock Analysis - Frequently Asked Questions

Is PennTex Midstream Partners a good dividend stock?: PennTex Midstream Partners (NASDAQ:PTXP) pays an annual dividend of $1.18 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 85.51%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for PTXP.
What other stocks do shareholders of PennTex Midstream Partners own?: Based on aggregate information from My MarketBeat watchlists, some companies that other PennTex Midstream Partners investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Ampliphi Biosciences (APHB), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP).
When did PennTex Midstream Partners IPO?: PennTex Midstream Partners (PTXP) raised $226 million in an initial public offering (IPO) on Thursday, June 4th 2015. The company issued 11,300,000 shares at $19.00-$21.00 per share. Citigroup, Barclays, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Deutsche Bank Securities, J.P. Morgan, SunTrust Robinson Humphrey, Tudor, Pickering, Holt & Co., Raymond James, Baird, Stifel and Wunderlich were co-managers.

This page (NASDAQ:PTXP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

PennTex Midstream Partners (PTXP) Stock Price, News & Analysis

About PennTex Midstream Partners Stock (NASDAQ:PTXP)

PTXP Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

PTXP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info